Article
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Genes and immunity - 1 Jan 2007
Monraats P S, Kurreeman F A S, Pons D, Sewgobind V D K D, de Vries F R, Zwinderman A H, de Maat M P M, Doevendans P A, de Winter R J, Tio R A, Waltenberger J, Huizinga T W J, Eefting D, Quax P H A, Frants R R, van der Laarse A, van der Wall E E, Jukema J W
Abstract excerpt
Genetic factors appear to be important in the process of restenosis after percutaneous coronary intervention (PCI), as well as in inflammation, a pivotal factor in restenosis. An important mediator in the inflammatory response is interleukin (IL)-10. Our aim was to study whether genetic variants in IL-10 predispose to the risk of restenosis. The GENetic DEterminants of Restenosis (GENDER) study included 3104...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.